FDA stability – Page 15

Why Shelf-Life Extension Fails When Original Study Design Is Weak

Addressing Failures in Shelf-Life Extension Due to Weak Study Design In the highly regulated pharmaceutical industry, robust stability study design is paramount for determining the shelf-life of products. A common…

Stability Commitments for First Commercial Batches After Approval

Addressing Regulatory Expectations for Stability Studies in First Commercial Batches In the complex landscape of pharmaceutical manufacturing, ensuring that first commercial batches meet regulatory expectations for stability is a significant…

Stability Study Design Problems in Outsourced Testing Programs

Addressing Challenges in Stability Study Design for Outsourced Testing Programs Stability study design errors can have far-reaching implications for pharmaceutical products, potentially leading to compromised product quality and regulatory non-compliance.…

How to Address Regulator Concerns on Limited Long-Term Stability Data

Addressing Regulatory Concerns Regarding Limited Long-Term Stability Data As pharmaceutical professionals, we often encounter regulatory inquiries about the robustness of long-term stability data for our products. Regulatory agencies emphasize the…

How to Align Stability Protocols with CTD Module 3 Expectations

Aligning Stability Protocols with CTD Module 3 Expectations: A Comprehensive Troubleshooting Guide In the pharmaceutical manufacturing landscape, misalignment of stability protocols with ICH CTD Module 3 requirements can lead to…

Regulatory Expectations for Stability Data in Variation and Supplement Filings

Understanding Regulatory Requirements for Stability Data in Variation and Supplement Filings In the pharmaceutical landscape, adherence to regulatory expectations for stability studies plays a crucial role in maintaining product quality…

Stability Design Errors in Photolabile Drug Products

Addressing Design Flaws in Stability Studies for Photolabile Drug Products Stability study design errors are a persistent challenge in the pharmaceutical industry, particularly for photolabile drug products. These errors can…

How to Create a Regulatory-Ready Stability Master Plan

Establishing a Compliance-Ready Stability Master Plan In the pharmaceutical industry, constructing a robust Stability Master Plan (SMP) is critical for meeting regulatory expectations for stability studies. This article will guide…

Why In-Use Stability Design Matters for Multidose Products

Addressing In-Use Stability Design Challenges for Multidose Products In the fast-paced world of pharmaceutical manufacturing, stability study design errors can lead to significant quality issues and regulatory compliance challenges. Numerous…

Stability Documentation Requirements for Product Lifecycle Management

Essential Strategies for Addressing Regulatory Expectations of Stability Documentation Pharmaceutical manufacturers frequently encounter challenges related to stability documentation requirements throughout the product lifecycle. A failure to adhere to these regulatory…

Stability Sample Quantity Planning Errors That Create Testing Shortfalls

Managing Stability Sample Quantity Planning Errors to Prevent Testing Shortfalls In the pharmaceutical industry, stability studies are critical for ensuring product quality and efficacy throughout its shelf life. However, stability…

Stability Sample Quantity Planning Errors That Create Testing Shortfalls

Understanding and Solving Stability Study Design Errors Impacting Testing Protocols In the highly regulated pharmaceutical industry, stability studies are crucial for ensuring product quality and compliance. Yet, errors in the…